Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucitanib in advanced solid tumors
NCT01283945Phase 2Completed
- Sponsor
- Servier
- Start
- Jul 2010
- Primary completion
- Sep 2016
- Countries
- 3
01
Overview
A Phase 2 trial of lucitanib in solid tumor, sponsored by Servier. Started Jul 2010; status: completed.
02
Drugs
lucitanib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01283945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01283945.